Gabify secures $175K pre-seed funding led by Inflection Point Ventures

Healthtech startup Gabify has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures.

The company has also received Rs 25 lakh in grant support under the Nidhi Seed Support Scheme from GHRTBI.

The fresh capital will be deployed towards clinical validation, product development, and team expansion. Gabify is also looking to widen its reach through a mix of B2B, B2C, and CSR-led distribution models, with a target to impact one million children by 2028.

Established in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk, the company is creating an AI-based platform to support early diagnosis and management of conditions like autism and ADHD.

Its solution leverages a dual AI system that analyses voice and visual cues—including speech patterns, facial expressions, and behavioural signals—based on clinically validated benchmarks, while incorporating human oversight for accuracy.

Gabify has already piloted its platform across more than 35 preschools and daycare centres, and is currently being adopted by schools, hospitals, and clinics.

The startup has also been recognised under initiatives such as DreamDeal by Anupam Mittal and is part of Inflection Point Ventures’ IdeaSchool programme, as it continues to scale its footprint in early-stage neurodevelopmental care.